Erector Spinae Block in Segmental Mastectomy.
Breast Cancer
About this trial
This is an interventional treatment trial for Breast Cancer focused on measuring regional anesthesia, erector spinae plane block, postoperative pain
Eligibility Criteria
Inclusion Criteria:
- Being volunteer
- Over 18 years old
- Unilateral segmental mastectomy patients
Exclusion Criteria:
- Emergency operations
- Younger than 18 years old,
- Non Volunteers
- ASA 3 and 4 patients
- Non-cooperative patients
Sites / Locations
- Maltepe University Medical FacultyRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
ESP block group
Control group
Unilateral ESP block will be applied as postoperative regional analgesia technique in addition to the multimodal therapy. Then she is positioned in a right lateral position to perform ESP blocks. The skin will be disinfected and ESP block at one side will be performed in the lateral decubitus position and at T4 transverse process level by using 10-MHz linear ultrasound probe (Logic Ebook XP General Electrics, USA). The probe will be located 3 cm lateral to T4 spinous process in longitudinal parasagittal orientation. An 8 cm 21 gauge needle (BRAUN Stimuplex A®, Germany) will be inserted by using out of the plane technique. The ESP blocks proceed with 15 ml of 0,25% bupivacaine, 7,5 ml 1 % lidocaine, ,7,5 ml 0,9 % NaCl as total 30 ml . The injections will be applied after the confirmation of location by hidrodisection developed anterior to erector spinae muscle with 1-2 ml of local anesthetic solution.
In this group, patients will receive only multimodal analgesic treatment including patient-controlled analgesia prepared with tramadol. Patient-controlled analgesia (PCA) with tramadol at 3mg/cc concentration is programmed with no basal infusion, demand dose 10 mg and 20-minute lock-out interval. Also, patients received 1 gr paracetamol in every 6 hours.